SUMMARY Data from a retrospective study in 41 patients is used to suggest an index of bone disease. This is designed as a means of collating available results, clarifying the significance of each in diagnosing either osteomalacia or osteoporosis, and reducing the significance of a single abnormal finding-for example, a raised alkaline phosphatase activity or low serum 25 hydroxy vitamin D, when the overall index score is low. Index scores above 35% would be diagnostic of osteomalacia; scores below 15% if associated with collapsed vertebrae suggest osteoporosis. Scores between 15% and 35% would indicate the need for a bone biopsy to discriminate between osteoporosis and osteomalacia.
Osteoporosis and osteomalacia are common forms of metabolic bone disease. They share certain features in common-namely, bone pain, decreased bone radio-density, and bone fractures.
I Differential diagnosis is often difficult without recourse to bone biopsy. Histological demonstration of excess osteoid with a mineralisation defect is diagnostic of osteomalacia. 2 The finding of normal bone composition (and decreased bone volume, where measured).
contributes to a diagnosis of osteoporosis, which is a diagnosis made by the exclusion of other forms of metabolic bone disease. ' Morgan4 suggested that osteomalacia could be diagnosed on the basis of biochemical and radiological abnormalities and clinical features and felt that bone biopsy was rarely necessary. In a retrospective study of 41 subjects we are examining this question, and for that reason we have designed and applied an index of metabolic bone disease (Table 1) as a means of collating and evaluating data from investigative procedures in such patients. The diagnostic procedures are each assigned a numerical value or score and the resultant score sheet is the index and is analagous to indices used in the diagnosis of thyroid disorders5 or in the assessment of disease status in cystic fibrosis. 6 The reduction of the need for an invasive test such as a bone biopsy is desirable and would be possible if *Research Fellow to Our Lady's Manor, Dalkey, Dublin.
Accepted for publication 30 September 1982 245 alternative non-invasive procedures could be shown to yield results upon which diagnosis could be firmly made. In this communication we hope to demonstrate the capacity of the index to separate those with The data were obtained from 41 subjects previously diagnosed as having metabolic bone disease. All subjects studied had normal renal function, and none had radiological evidence of Paget's disease. They were divided into two groups. Tables 2 and 3 McKenna, Freaney, Casey, Towers, Muldowney abnormalities. One patient with osteomalacia had normal serum chemistry, four patients had a single abnormality, 10 patients had two abnormalities and 11 patients had three abnormalities ( Table 2 ). Two of three osteoporotic patients with a low calciumphosphate product, and three of four osteomalacic subjects with a normal serum calcium-phosphate product had total serum calcium "corrected for" albumin."9 Despite "correction" of total calcium for albumin in these subjects, the calcium-phosphate product remained discordant.
RADIOLOGY
Pseudofractures normally associated with osteomalacia were present in six of 26 (23%) patients with osteomalacia and in one of 15 (7%) of subjects with osteoporosis. Collapsed vertebrae and decreased vertebral body density were by definition present in all subjects with osteoporosis, but also present in seven of 20 (35%) and 16 of 20 (80%) respectively of patients with osteomalacia.
INDEX
Collating the results of the investigations in the proposed index gave osteomalacic patients a mean (±SD) percentage score of 54.8 ± 22-3% (range 8-92%) and patients with osteoporosis 8-4 ± 10-2% (range 0-30%). Fig. 1 demonstrates the minimal degree of overlap between the two groups using the
Results

CLINICAL FEATURES
Limb pain was present in 18 of 26 (69%) subjects with osteomalacia and in three of 15 (20%) subjects with osteoporosis. Back pain was present in all subjects with osteoporosis and in 12 of 26 (46%) subjects with osteomalacia. Back pain only was present in three of 26 (12%) subjects with osteomalacia. Five subjects (19%) with osteomalacia did not give a history of bone pain. Proximal myopathy was a feature occurring only in osteomalacia in eight of 26 (31%) subjects. individual indicants listed in the index are shown in Table 4 . No single indicant approaches the degree of correlation between the osteoid volume and the index score. The index gives a higher risk ratio and a lower degree of misclassification than any single indicant (Table 5) . Table 5 also lists the sensitivity, The maximum number of lamellae per osteoid seam was >3, in four of 15 (27%) subjects with osteoporosis and in 23 of 26 (88%) subjects with osteomalacia. There was a highly significant correlation (r = 0-91, Fig. 3 ) between the osteoid volume and the number of lamellae. Bone ash content was low (<52%) in 17 of 23 osteomalacic patients, but lacked specificity as it was also low in eight of 14 osteoporotic patients. There was significant negative correlation (r = -0-33, p < 0.05) between bone ash content and osteoid volume. Bone calcium although measured was excluded from the index on the basis that % bone ash yielded largely the same information, and was easier to measure. In a large series with various disorders of calcium metabolism a high degree of correlation (r = 0926, p < 0-001) was seen between % bone ash and bone calcium (Fig. 4) .
Discussion
The index, which represents the cumulative points scored for all the parameters assessed in each patient, discriminates with a minimum of overlap between the osteoporotic and osteomalacic groups (Fig. 1) . A score above 35% would be diagnostic of osteomalacia. A score below 15% would exclude osteomalacia in all but one case, and if associated with collapsed vertebrae (or decreased bone density) would suggest a diagnosis of osteoporosis (or osteopenia). A score below 15% with a normal spinal x-ray should exclude both these forms of metabolic bone disease. A score between 15 and 35% would indicate that a bone biopsy is needed for definitive diagnosis. Partial validation of this index of metabolic bone disease lies in its close correlation with the osteoid volume in biopsy specimens, which allows the degree of demineralisation-that is, excess osteoid, to be predicted with some degree of confidence from the index score (Fig. 2) . In this retrospective study, nine patients with osteoporosis and 21 patients with osteomalacia could have their correct diagnosis predicted by use ofthe index. Ten patients wouldneed a bonebiopsy to make a definitive diagnosis. Complete validation of the index will depend on its application in a larger prospective study. In its present form it is easy to apply and suggests a new method of assessing the diagnostic significance of the tests usually performed. If newer non-invasive procedures such as bone scanninge or photon beam absorptiometry2' could give useful information when results of the index are equivocal (15 to 35%), further reduction in the numbers of subjects needing bone biopsy may be achieved.
The prevalence of osteomalacia and osteoporosis will vary with age and population studied. Is the index still useful as the disease prevalence changes? This question is answered by considering its positive and negative predictive values over a wide range of disease prevalences (Fig. 5) . It is clear that even when the prevalence of disease is as low as 5%, the index is still useful in a positive and negative predictive way. and thus determine the presence or absence of osteomalacia. While we are aware that this does not give a complete picture of bone status in osteomalacia it is a simple method within the competence of any laboratory. Quantitative assessment of osteoid, which is a tedious procedure, need not always be done. Analysis of osteoid seam thickness by counting the number of lamellae (bright lines) gives reliable information in this and previously reported studies.'314 Mineral content of bone tissue in biopsy samples as measured by bone ash determination was studied with regard to its correlation with osteoid volume, and with regard to its diagnostic value in osteomalacia. Data show significant but low correlation (r = -0-33, p < 0-05) between osteoid volume and % bone ash. Morgan4 in a previous study comparing bone ash and amount of osteoid reported similar findings. Low specificity limits its diagnostic usefulness. Subjective assessment of the quantity of osteoid (by an experienced pathologist) agreed with the disease classification determined by quantitative assessment inf 37 of 41 cases (Table 2 ). In the four discordant cases, subjective assessment indicated a mild excess of osteoid.
In summary, an index of metabolic bone disease is presented that is simple to apply, gives good separation between subjects with and without osteomalacia, and indicates when a bone biopsy is necessary. Based on the evidence from this study, bone biopsy is not necessary to confirm a diagnosis of osteomalacia in patients with scores above 35%.
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